Valley Wealth Managers’s NovoCure NVCR Stock Holding History

Valley Wealth Managers’s Portfolio NVCR Stock Details NVCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-100	Closed	-$1K	–	161
2017 Q1	$1K	Hold	100	–	–	﹤0.01%	200
2016 Q4	$1K	Buy	+100	New	+$804	﹤0.01%	248

Other funds holding NVCR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return

HCM

Highline Capital Management New York $53.5M AUM 21.72% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Valley Wealth Managers's NVCR Position: Q2 2017 in Review

Valley Wealth Managers sold out of NovoCure (NVCR) in Q2 2017, closing a stake of 100 shares — an estimated $1K sold.

Valley Wealth Managers first reported a position in NVCR in Q4 2016 and held it in 2 quarters. The position peaked at $1K in Q1 2017. 85 funds tracked by Wall St. Rank hold NVCR as of Q2 2017.

Valley Wealth Managers reported no remaining NovoCure position as of Q2 2017 after selling out during the quarter.
Valley Wealth Managers sold 100 NovoCure shares in Q2 2017, an estimated $1K.
Valley Wealth Managers first reported a position in NovoCure in Q4 2016 and held it in 2 quarters.
Valley Wealth Managers's NovoCure position peaked at $1K in Q1 2017.
85 funds tracked by Wall St. Rank held NovoCure as of Q2 2017.

Based on Valley Wealth Managers's 13F filing for Q2 2017, filed 13 Jul 2017.